ES490031A0 - Procedimiento para la preparacion de nuevos derivados de prostaglandina - Google Patents

Procedimiento para la preparacion de nuevos derivados de prostaglandina

Info

Publication number
ES490031A0
ES490031A0 ES490031A ES490031A ES490031A0 ES 490031 A0 ES490031 A0 ES 490031A0 ES 490031 A ES490031 A ES 490031A ES 490031 A ES490031 A ES 490031A ES 490031 A0 ES490031 A0 ES 490031A0
Authority
ES
Spain
Prior art keywords
prostaglandina
procedure
preparation
new derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES490031A
Other languages
English (en)
Other versions
ES8202539A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES490031A0 publication Critical patent/ES490031A0/es
Publication of ES8202539A1 publication Critical patent/ES8202539A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
ES490031A 1979-04-06 1980-03-28 Procedimiento para la preparacion de nuevos derivados de prostaglandina Expired ES8202539A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792913856 DE2913856A1 (de) 1979-04-06 1979-04-06 Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe

Publications (2)

Publication Number Publication Date
ES490031A0 true ES490031A0 (es) 1982-02-01
ES8202539A1 ES8202539A1 (es) 1982-02-01

Family

ID=6067601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490031A Expired ES8202539A1 (es) 1979-04-06 1980-03-28 Procedimiento para la preparacion de nuevos derivados de prostaglandina

Country Status (11)

Country Link
US (1) US4304783A (es)
EP (1) EP0019069B1 (es)
JP (1) JPS55141465A (es)
AT (1) ATE8621T1 (es)
AU (1) AU544615B2 (es)
CA (1) CA1152505A (es)
DE (2) DE2913856A1 (es)
ES (1) ES8202539A1 (es)
HU (1) HU184735B (es)
IL (1) IL59768A (es)
ZA (1) ZA802011B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JPS60181068A (ja) * 1984-02-29 1985-09-14 Teijin Ltd 6−置換プロスタグランジンe↓1類およびその製造法
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US4791133A (en) * 1987-06-26 1988-12-13 G. D. Searle & Co. Phenylene, furyl, and thienyl leukotriene B4 analogues
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
AU2603301A (en) 1999-12-22 2001-07-03 Alcon Universal Limited 6-keto prostaglandin F1alpha and analogs for treating dry eye

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物

Also Published As

Publication number Publication date
ZA802011B (en) 1981-04-29
JPS55141465A (en) 1980-11-05
ATE8621T1 (de) 1984-08-15
US4304783A (en) 1981-12-08
DE2913856A1 (de) 1980-10-23
ES8202539A1 (es) 1982-02-01
IL59768A (en) 1986-01-31
EP0019069A2 (de) 1980-11-26
AU5717080A (en) 1980-10-09
EP0019069B1 (de) 1984-07-25
HU184735B (en) 1984-10-29
AU544615B2 (en) 1985-06-06
IL59768A0 (en) 1980-06-30
CA1152505A (en) 1983-08-23
EP0019069A3 (en) 1981-01-14
DE3068652D1 (en) 1984-08-30

Similar Documents

Publication Publication Date Title
ES498072A0 (es) Procedimiento para la preparacion de 2-azidometil-5-fenil-1h-2,3-dihidro-1,4-benzodiazepinas
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
AR219561A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-piperidino-6,7-dialcoxi-ftalazina utiles como agentes terapeuticos
ES495267A0 (es) Procedimiento para la obtencion de derivados de triazo- lil-a-fluorpinacolilo,acilados de efecto fungicida
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
ES490031A0 (es) Procedimiento para la preparacion de nuevos derivados de prostaglandina
ES492142A0 (es) Procedimiento para la produccion de oxidasa de alcohol
ES489184A0 (es) Procedimiento para la produccion de derivados de feobromina.
AR225276A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoroetano
ES492537A0 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES488709A0 (es) Procedimiento para la preparacion de compuestos diorganomag-nesicos,r2mg
AR218060A1 (es) Procedimiento para la preparacion de derivados de acido 11-oxo-11h-pirido(2,1-b)quinazolina-2-carboxilico
ES497143A0 (es) Procedimiento para la fabricacion de derivados del pirazol
ES499913A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
ES493649A0 (es) Procedimiento para la fabricacion de 4-tiazolidonas,2-subs- tituidas
SE8205383D0 (sv) 1-acyl-2-imidazolin och forfarande for dess framstellning
MX3745E (es) Procedimiento para la preparacion de acido 6,11-dihidro-11-oxodibenz-(b,e)oxepin-2-alcanoico
AR212174A1 (es) Procedimiento para la preparacion de derivados de las 1-aminometil-6,7-dihidroxi-1,2,3,4-tetrahidroisoquinoleinas
MX6164E (es) Procedimiento microbiologico mejorado para la preparacion del acido 2,5-dicetogluconico
AR220127A1 (es) Procedimiento para la preparacion de d-homopregna-4,8-dieno-3,20-dionas
ES494606A0 (es) Procedimiento para la obtencion de nuevos derivados de 4,7- fenantrolina
ES497532A0 (es) Procedimiento para la preparacion de compuestos derivados den-fenil-pirrolidin-2,5-diona
AR225039A1 (es) Procedimiento para la preparacion de n-dialquilaminometil-s,s-diarilsulfoximidas
AR218703A1 (es) Procedimiento para la fabricacion de derivados del acido 2-bencil-1,2-dihidro-1-oxoftalazin-4-ilacetico